Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
dried cranberry
- Development stage
- Unknown
- Administration
- Oral
01
Overview
Dried cranberry is a processed fruit product derived from cranberries (Vaccinium macrocarpon), rich in bioactive compounds such as polyphenols, anthocyanins, and proanthocyanidins. It is consumed as a dietary supplement and nutraceutical due to its antioxidant, anti-inflammatory, and gut microbiome modulating properties. Clinical studies have investigated its potential benefits in conditions such as overactive bladder, cognitive decline in aging, non-alcoholic fatty liver disease, and the prevention of urinary tract infections by inhibiting bacterial adhesion.
- Other names
- dried cranberry powderfreeze-dried cranberry powdersweetened dried cranberriesFCPSDC
02
Targets
PapG (PapG adhesin)FimH (Type 1 fimbrial adhesin)
Beyond the preview
Go deeper on dried cranberry.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on dried cranberry.